Hazel and other sources of paclitaxel and related compounds

Mariangela Miele, Anna Maria Mumot, Achille Zappa, Paolo Romano, Laura Ottaggio

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Taxanes form a large family of compounds, the most famous of which is paclitaxel, an effective antitumor drug currently used against various cancers. First approved for the treatment of ovarian and breast cancer, it was subsequently endorsed for the treatment of many other cancer pathologies. Originally extracted from the bark of Taxus brevifolia, it has also been found in other Taxus species. Most of the drug for clinical use is currently produced by semi-synthesis, starting from a natural precursor, 10-deacetylbaccatin III recovered from the needles of Taxus baccata. The yield of paclitaxel and its precursors from yew is very low, and is not sufficient to satisfy the commercial requirements. Many attempts have been made to explore new paclitaxel-producing species including microorganisms. However, the availability of paclitaxel and related compounds is still low. The discovery of taxanes in differentiated and undifferentiated tissue of Corylus avellana suggested that the production of these compounds is not a peculiarity of the genus Taxus, giving hope for the future availability of these compounds. Here we review works aimed at exploring new paclitaxel-producing organisms with different ecology to Taxus plants. Particular focus has been placed on highlighting the discovery of taxanes in angiosperm plants. Thus, it is conceivable that, by developing appropriate methodologies, new plant species could be employed for the commercial production of paclitaxel and other antineoplastic compounds.

Original languageEnglish
Pages (from-to)211-225
Number of pages15
JournalPhytochemistry Reviews
Volume11
Issue number2-3
DOIs
Publication statusPublished - Jun 2012

Fingerprint

paclitaxel
Taxus
Paclitaxel
taxanes
Taxoids
Antineoplastic Agents
Taxus brevifolia
Corylus
Taxus baccata
Angiosperms
drugs
Corylus avellana
neoplasms
ovarian neoplasms
Ecology
breast neoplasms
Ovarian Neoplasms
Needles
Angiospermae
Neoplasms

Keywords

  • Angiosperms
  • Anticancer drugs
  • Antimitotic compounds
  • Corylus avellana
  • Taxanes

ASJC Scopus subject areas

  • Plant Science
  • Biotechnology

Cite this

Hazel and other sources of paclitaxel and related compounds. / Miele, Mariangela; Mumot, Anna Maria; Zappa, Achille; Romano, Paolo; Ottaggio, Laura.

In: Phytochemistry Reviews, Vol. 11, No. 2-3, 06.2012, p. 211-225.

Research output: Contribution to journalArticle

Miele, Mariangela ; Mumot, Anna Maria ; Zappa, Achille ; Romano, Paolo ; Ottaggio, Laura. / Hazel and other sources of paclitaxel and related compounds. In: Phytochemistry Reviews. 2012 ; Vol. 11, No. 2-3. pp. 211-225.
@article{ea87ffc4938e49d2ad82c84f1dc505e4,
title = "Hazel and other sources of paclitaxel and related compounds",
abstract = "Taxanes form a large family of compounds, the most famous of which is paclitaxel, an effective antitumor drug currently used against various cancers. First approved for the treatment of ovarian and breast cancer, it was subsequently endorsed for the treatment of many other cancer pathologies. Originally extracted from the bark of Taxus brevifolia, it has also been found in other Taxus species. Most of the drug for clinical use is currently produced by semi-synthesis, starting from a natural precursor, 10-deacetylbaccatin III recovered from the needles of Taxus baccata. The yield of paclitaxel and its precursors from yew is very low, and is not sufficient to satisfy the commercial requirements. Many attempts have been made to explore new paclitaxel-producing species including microorganisms. However, the availability of paclitaxel and related compounds is still low. The discovery of taxanes in differentiated and undifferentiated tissue of Corylus avellana suggested that the production of these compounds is not a peculiarity of the genus Taxus, giving hope for the future availability of these compounds. Here we review works aimed at exploring new paclitaxel-producing organisms with different ecology to Taxus plants. Particular focus has been placed on highlighting the discovery of taxanes in angiosperm plants. Thus, it is conceivable that, by developing appropriate methodologies, new plant species could be employed for the commercial production of paclitaxel and other antineoplastic compounds.",
keywords = "Angiosperms, Anticancer drugs, Antimitotic compounds, Corylus avellana, Taxanes",
author = "Mariangela Miele and Mumot, {Anna Maria} and Achille Zappa and Paolo Romano and Laura Ottaggio",
year = "2012",
month = "6",
doi = "10.1007/s11101-012-9234-8",
language = "English",
volume = "11",
pages = "211--225",
journal = "Phytochemistry Reviews",
issn = "1568-7767",
publisher = "Springer Netherlands",
number = "2-3",

}

TY - JOUR

T1 - Hazel and other sources of paclitaxel and related compounds

AU - Miele, Mariangela

AU - Mumot, Anna Maria

AU - Zappa, Achille

AU - Romano, Paolo

AU - Ottaggio, Laura

PY - 2012/6

Y1 - 2012/6

N2 - Taxanes form a large family of compounds, the most famous of which is paclitaxel, an effective antitumor drug currently used against various cancers. First approved for the treatment of ovarian and breast cancer, it was subsequently endorsed for the treatment of many other cancer pathologies. Originally extracted from the bark of Taxus brevifolia, it has also been found in other Taxus species. Most of the drug for clinical use is currently produced by semi-synthesis, starting from a natural precursor, 10-deacetylbaccatin III recovered from the needles of Taxus baccata. The yield of paclitaxel and its precursors from yew is very low, and is not sufficient to satisfy the commercial requirements. Many attempts have been made to explore new paclitaxel-producing species including microorganisms. However, the availability of paclitaxel and related compounds is still low. The discovery of taxanes in differentiated and undifferentiated tissue of Corylus avellana suggested that the production of these compounds is not a peculiarity of the genus Taxus, giving hope for the future availability of these compounds. Here we review works aimed at exploring new paclitaxel-producing organisms with different ecology to Taxus plants. Particular focus has been placed on highlighting the discovery of taxanes in angiosperm plants. Thus, it is conceivable that, by developing appropriate methodologies, new plant species could be employed for the commercial production of paclitaxel and other antineoplastic compounds.

AB - Taxanes form a large family of compounds, the most famous of which is paclitaxel, an effective antitumor drug currently used against various cancers. First approved for the treatment of ovarian and breast cancer, it was subsequently endorsed for the treatment of many other cancer pathologies. Originally extracted from the bark of Taxus brevifolia, it has also been found in other Taxus species. Most of the drug for clinical use is currently produced by semi-synthesis, starting from a natural precursor, 10-deacetylbaccatin III recovered from the needles of Taxus baccata. The yield of paclitaxel and its precursors from yew is very low, and is not sufficient to satisfy the commercial requirements. Many attempts have been made to explore new paclitaxel-producing species including microorganisms. However, the availability of paclitaxel and related compounds is still low. The discovery of taxanes in differentiated and undifferentiated tissue of Corylus avellana suggested that the production of these compounds is not a peculiarity of the genus Taxus, giving hope for the future availability of these compounds. Here we review works aimed at exploring new paclitaxel-producing organisms with different ecology to Taxus plants. Particular focus has been placed on highlighting the discovery of taxanes in angiosperm plants. Thus, it is conceivable that, by developing appropriate methodologies, new plant species could be employed for the commercial production of paclitaxel and other antineoplastic compounds.

KW - Angiosperms

KW - Anticancer drugs

KW - Antimitotic compounds

KW - Corylus avellana

KW - Taxanes

UR - http://www.scopus.com/inward/record.url?scp=84876410910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876410910&partnerID=8YFLogxK

U2 - 10.1007/s11101-012-9234-8

DO - 10.1007/s11101-012-9234-8

M3 - Article

VL - 11

SP - 211

EP - 225

JO - Phytochemistry Reviews

JF - Phytochemistry Reviews

SN - 1568-7767

IS - 2-3

ER -